Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Health Services Research|November 22, 2021
Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional MedicareKelly E Anderson, Daniel Polsky, Sydney Dy, et al.
Health Affairs (Project Hope)|September 7, 2017
Most Marketplace Plans Included At Least 25 Percent Of Local-Area Physicians, But Enrollment Disparities RemainedAditi P Sen, Lena M Chen, Donald F Cox, et al.
The American Journal of Managed Care|July 27, 2021
Large self-insured employers lack power to effectively negotiate hospital pricesMatthew D Eisenberg, Mark K Meiselbach, Ge Bai, et al.
The Milbank Quarterly|November 23, 2021
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care ProgramAditi P Sen, Yashaswini Singh, Mark K Meiselbach, et al.
JAMA Health Forum|August 17, 2022
Physician Network Breadth and Plan Quality Ratings in Medicare AdvantageAditi P Sen, Mark K Meiselbach, Kelly E Anderson, et al.
The American Journal of Managed Care|July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugsKelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.
The American Journal of Managed Care|December 14, 2020
Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare populationBryan C Hambley, Kelly E Anderson, Satish P Shanbhag, et al.
JAMA Internal Medicine|April 26, 2021
Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured PatientsAditi P Sen, Mark K Meiselbach, Yang Wang, et al.
JAMA Internal Medicine|March 29, 2021
Characteristics of Copayment Offsets for Prescription Drugs in the United StatesAditi P Sen, So-Yeon Kang, Emaan Rashidi, et al.
Pageof 3